LXEO
Conviction 20HealthcareScan · Fri, Oct 2, 2026Lexeo Therapeutics, Inc. (LXEO) closed at $3.53 (-2.49%) on Oct 2, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 37, RS Rating 19, -66.7% from its 52-week high, -63.2% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Lexeo Therapeutics, Inc.: Unregistered equity sale (dilution)SEC EDGAR · Tue, Sep 29, 2026
Congress activity
Disclosed STOCK Act trades in LXEO
Insider activity
SEC Form 4 transactions in LXEO · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Townsend Richard Nolan Chief Executive Officer · Common Stock · 2026-08-18 | Sell | 3.35K | $17K | 2026-08-18 | 2026-08-19 |
Otero Jose Manuel Chief Operating Officer · Common Stock · 2026-08-18 | Sell | 1.3K | $6K | 2026-08-18 | 2026-08-19 |
Tamayo Louis Edward Chief Financial Officer · Common Stock · 2026-08-18 | Sell | 4.12K | $20K | 2026-08-18 | 2026-08-19 |
Altschuler Steven Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
Agger Mette Kirstine Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
CHOLMONDELEY PAULA H Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
COOPERSTONE BRENDA Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
DIAZ REINALDO M Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
Van Hauwermeiren Timothy Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
Tanguler Tolga Director · Stock Option (right to buy) · 2026-06-25 | Grant | 35K | — | 2026-06-25 | 2026-06-29 |
SEC filings
EDGAR filings in LXEO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.